Sosei Heptares Revenue and Competitors

Tokyo,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sosei Heptares's estimated annual revenue is currently $35.3M per year.(i)
  • Sosei Heptares's estimated revenue per employee is $155,000

Employee Data

  • Sosei Heptares has 228 Employees.(i)
  • Sosei Heptares grew their employee count by 9% last year.

Sosei Heptares's People

NameTitleEmail/Phone
1
EVP, Chief StaffReveal Email/Phone
2
VP, Head DiscoveryReveal Email/Phone
3
Head Human ResourcesReveal Email/Phone
4
Quality Assurance OfficerReveal Email/Phone
5
SVP Corporate StrategyReveal Email/Phone
6
Head IPReveal Email/Phone
7
General CounselReveal Email/Phone
8
Head FinanceReveal Email/Phone
9
Head Clinical OperationsReveal Email/Phone
10
Head Human ResourcesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Sosei Heptares?

We are an international biopharmaceutical group focused on the discovery and early development of new medicines originating from our proprietary GPCR-targeted StaR® technology and structure-based drug design platform capabilities. We are advancing a broad and deep pipeline of novel medicines across multiple therapeutic areas, including neurology, immunology, gastroenterology and inflammatory diseases. We have established partnerships with some of the world's leading pharmaceutical companies, including AbbVie, AstraZeneca, Genentech (Roche), Novartis, Pfizer and Takeda and additionally with multiple emerging technology companies. Sosei Heptares is headquartered in Tokyo, Japan with corporate and R&D facilities in Cambridge, UK. Sosei Heptares is the corporate brand of Sosei Group Corpoation, which is listed on the Tokyo Stock Exchange (ticker: 4565). For more information, please visit www.soseiheptares.com

keywords:N/A

N/A

Total Funding

228

Number of Employees

$35.3M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sosei Heptares News

2022-04-20 - Sosei Heptares to Embed Agile Operating Model and ...

Sosei Heptares to Embed Agile Operating Model and Enhance its Translational Medicine Capabilities through Strategic Collaboration with...

2022-04-20 - Sosei Heptares to Embed Agile Operating Model and ...

The collaboration aims to build upon Sosei Heptares' world-leading G protein-coupled receptor (GPCR) structure-based drug design (SBDD) platform...

2022-03-22 - Sosei Heptares confirms new leadership focused on driving growth from its Granta Park R&D centre

Sosei Heptares has unveiled a raft of senior leadership changes as it focuses on driving growth out of its R&D expertise at Granta Park.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.3M2289%N/A
#2
$88.2M24311%N/A
#3
$40.5M2549%N/A
#4
$37.3M261110%$260.4M
#5
$39.2M27440%N/A